RFA Ticker, 3/7/16

ticker

Just one RFA last week, and it wasn’t for ME/CFS. The wait continues.

  • Total RFAs Issued by NIH: 150 (October 2015 to date)
  • Total Dollars Committed to RFAs: $1,612,990,000 (October 2015 to date)
  • Total RFAs for ME/CFS: ZERO (October 2015 to date)
Week Beginning RFAs Issued Total Commitment RFAs for ME/CFS
2/29/16 1 $1,890,000 Zero
2/22/16 9 $30,100,000 Zero
2/15/16 4 $26,500,000 Zero
2/8/16 5 $9,500,000 Zero
2/1/16 8 $26,000,000 Zero
1/25/16 6 $11,550,000 Zero
1/18/16 2 $4,500,000 Zero
1/11/16 10 $71,200,000 Zero
1/4/16 0 $0 Zero
12/28/15 0 $0 Zero
12/21/15 3 $10,260,000 Zero
12/18/15 5 $20,260,000 Zero
12/11/15 27 $765,090,000 Zero
12/4/15 6 $26,600,000 Zero
11/27/15 4 $21,000,000 Zero
11/20/15 15 $134,400,000 Zero
11/13/15 2 $16,100,000 Zero
11/6/15 10 $22,850,000 Zero
10/30/15 7 $49,800,000 Zero
10/23/15 10 $33,200,000 Zero
10/16/15 0 $0 Zero
10/9/15 13 $332,450,000 Zero

If you want more background on the RFA Ticker, read the inaugural post.

This entry was posted in Advocacy, Research and tagged , , , , , , , , , , , . Bookmark the permalink.

2 Responses to RFA Ticker, 3/7/16

  1. Joe Landson says:

    For a full hour teleconference, the NIH can schedule
    Dr. Collins
    Dr. Koroshetz
    Dr. Holets-Whittemore
    Dr. Nath (from our embassy in Liberia, was it?) and
    Dr. Walitt
    But no, the NIH can’t find a single dime for ME/CFS RFAs, because, bureaucracy.

  2. Rivka says:

    Someone posted this on Phx Rising re: the NIH teleconference this week. I have not gone to the transcript to see if this is true or not. Has anyone else done that yet? I missed hearing this during the call itself. — Rivka

    Here is a quote from Francis Collins about RFAs toward the beginning of the call:
    “So, in addition, on the extramural side, a vigorous re-invigorated trans-NIH Working Group is working to divine the strategic areas of research that would form the basis for a Request for Applications to the extramural community, both in the short term and in the longer term, and Dr. Koroshetz can tell you more about where we are about that particular set of discussions. We’re quite serious about looking for opportunities to expand our research in this area and to recruit new investigators into the field, bringing new eyes and new brains into the issue of trying to understand the puzzling aspects that previously have eluded us. “

Comments are closed.